GBp 18.25
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -5.4 Million | -3.46 Million | -717.49 Thousand | -110.8 Thousand | -55.95 | -95.62 |
Net Income | -5.88 Million | -3.8 Million | -1.2 Million | -144.33 Thousand | -309.60 | -125.44 |
Depreciation & Amortization | - | - | - | - | - | 136.79 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 527.93 | 4040.00 | 97.74 Thousand | 13.24 Thousand | 9.22 | - |
Change in working capital | -50.9 Thousand | -111.46 Thousand | 385.87 Thousand | 13.2 Thousand | - | 28.54 |
Other non-cash items | 841.28 Thousand | 446.4 Thousand | 3579.00 | 7087.00 | 244.43 | -135.51 |
Investing Cash Flow | -8.85 Million | -4.4 Million | -695.92 Thousand | -9825.00 | -11.61 | -129.54 |
Investments in PPE | -8.85 Million | -4.4 Million | -695.92 Thousand | -9825.00 | -11.61 | -129.54 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 8.19 Million | 17 Million | 4.56 Million | 132.57 Thousand | 144.48 | 45.07 |
Debt repayment | - | - | -47.69 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 8.19 Million | 17.01 Million | 4.61 Million | 132.57 Thousand | - | - |
Other Financing Activities | 8192.35 | -6751.00 | -3580.00 | 132.57 | 144.48 | 45.07 |
Accounts receivables | -313.35 Thousand | -226.87 Thousand | - | - | - | 28.54 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 262.44 Thousand | 115.41 Thousand | -51.46 | - | - | - |
Cash at beginning of period | 12.36 Million | 3.23 Million | 95.63 Thousand | 83.69 Thousand | 6.77 | 186.86 |
Cash at end of period | 6.2 Million | 12.36 Million | 3.23 Million | 95.63 Thousand | 83.69 | 6.77 |
Capital Expenditure | -8.85 Million | -4.4 Million | -695.92 Thousand | -9825.00 | -11.61 | -129.54 |
Effect of forex changes on cash | -98.32 Thousand | -5261.00 | -14.05 Thousand | - | - | - |
Net cash flow / Change in cash | -6.16 Million | 9.13 Million | 3.13 Million | 11.94 Thousand | 76.92 | -180.09 |
Free Cash Flow | -14.26 Million | -7.86 Million | -1.41 Million | -120.62 Thousand | -67.56 | -225.17 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1430.60 | -1430.60 | -5.88 Million | -1306.30 | -1306.30 | -3.27 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 300.00 | 300.00 | 527.93 | 263.97 | 263.97 | - |
Change in working capital | 198.66 | 198.66 | -50.9 Thousand | -236.48 | -236.48 | 182.56 Thousand |
Other non-cash items | 414.24 | 414.24 | 841.28 Thousand | -153.80 | -153.80 | 377.67 Thousand |
Investing Cash Flow | -2400.02 | -2400.02 | -8.85 Million | -1685.22 | -1685.22 | -5.48 Million |
Investments in PPE | -2400.02 | -2400.02 | -8.85 Million | -1685.22 | -1685.22 | -5.48 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | 8.19 Million | 3903.08 | 3903.08 | 396 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 8.19 Million | 7.79 Million | - | 396 Thousand |
Other Financing Activities | - | - | 8192.35 | 3903.08 | 3903.08 | 193.10 |
Accounts receivables | 198.66 | 198.66 | -313.35 Thousand | -236.48 | -236.48 | 159.6 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 262.44 Thousand | 239.48 Thousand | - | 22.96 Thousand |
Cash at beginning of period | - | - | 12.36 Million | 4.63 Million | - | 12.36 Million |
Cash at end of period | -3083.03 | -3083.03 | 6.2 Million | 6.2 Million | 781.64 | 4.63 Million |
Capital Expenditure | -2400.02 | -2400.02 | -8.85 Million | -1685.22 | -1685.22 | -5.48 Million |
Effect of forex changes on cash | -165.31 | -165.31 | -98.32 Thousand | -3.60 | -3.60 | -45.56 |
Net cash flow / Change in cash | -3083.03 | -3083.03 | -6.16 Million | 1.56 Million | 781.64 | -7.72 Million |
Free Cash Flow | -2917.72 | -2917.72 | -14.26 Million | -3117.84 | -3117.84 | -8.03 Million |
ACROW
688070
BIOFILCHEM
ASSA
BFS-PE
SACH